TRIOXBIO
TrioxBio is a clinical-stage biotech company specializes in the development and commercialization of proprietary synthetic small molecules to treat diseases and medical conditions related to the pathological overproduction of Nitric Oxide (NO). With this, TrioxBio can provide patients with better access to high-quality, cost-effective medicines in key therapeutic areas.
TRIOXBIO
Industry:
Biotechnology Health Care Medical
Founded:
2015-05-01
Address:
Ramat Gan, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.trioxbio.com
Total Employee:
1+
Status:
Active
Contact:
+972-3-6114543
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving Iomart
Similar Organizations
AQTIS Medical
Sinclair company, specializes in the research, development, manufacturing and commercialization of innovative injectable medical devices.
Bio-gen Extracts
Bio-gen Extracts specializes in the development and production of scientifically-backed health ingredients.
CanSino Biologics
CanSino Biologics focuses on the R&D, manufacturing, and commercialization of vaccine products for human use.
Euchloe Bio
Euchloe Bio specializes in the discovery, development, engineering and commercialization of novel, fully-human antibodies.
NasasBiotech
Biomedicine start-up developing and commercializing metastatic tumor cells capturing devices.
Regenero
Regenero specializes in the development and commercialization of innovative cellular therapies.
Rusan Pharma
Rusan Pharma specializes in the research, development, and marketing of various narcotics and psychotropic drugs.
Sanare Bioscience
Sanare Bioscience specializes in the development and commercialization of medical products that improve patient outcomes.
Current Employees Featured
Founder
Official Site Inspections
http://www.trioxbio.com
- Host name: daisy.specialservers.com
- IP address: 5.77.41.163
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "TrioxBio"
TrioxBio
TrioxBio Inc., a Delaware Corporation, is a clinical-stage biotech company specializing in the development of compounds to treat diseases and medical conditions related to the pathological overproduction of Nitric Oxide (NO)-link …See details»
TrioxBio - Crunchbase Company Profile & Funding
TrioxBio is a clinical-stage biotech company specializes in the development and commercialization of proprietary synthetic small molecules to treat diseases and medical …See details»
Who we are - TrioxBio
The TrioxBio Vision Our vision is a reality of life-saving medications intended to solve as yet unmet needs where Nitric Oxide access plays a major role. The mission of TrioxBio Inc. is a …See details»
Triox Bio Company Profile | Management and Employees List
TrioxBio Inc. is a clinical-stage biopharmaceutical company specializing in the development of compounds to treat diseases and medical conditions related to the pathological overproduction …See details»
TrioxBio - LinkedIn
TrioxBio's API, S-ethylisothiouronium diethylphosphate, MTR-104, is a Nitric Oxide Synthase (NOS) inhibitor which blocks the production of nitric oxide, preventing the dilation of blood vessels ...See details»
Investor Relations - TrioxBio
The CEO of TrioxBio is the founder and former CEO of the SK- Pharma Group, a global pharmaceutical company that manufactures, sells and markets generic pharmaceutical products in over 15 countries worldwide. At SK-Pharma he …See details»
Triox Bio - Overview, News & Similar companies | ZoomInfo.com
Who is Triox Bio. TrioxBio Inc. is a clinical-stage biopharmaceutical company specializing in the development of compounds to treat diseases and medical conditions r elated to the …See details»
TrioxBio - VentureRadar
TrioxBio Inc. is a clinical-stage biotech company specializing in the development of compounds to treat diseases and medical conditions related to the pathological overproduction of Nitric Oxide …See details»
Trioxbio. Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Trioxbio. Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
TrioxBio - Crunchbase
TrioxBio specializes in the development and commercialization of proprietary synthetic small molecules.See details»
TrioxBio - Nitric Oxide Synthase Inhibitors | Startup Nation Finder
May 29, 2018 TrioxBio develops and commercializes proprietary synthetic small molecules to treat pathologic states caused by the overproduction of nitric oxide. The company's API, S …See details»
TrioxBio - Contacts, Employees, Board Members, Advisors & Alumni
TrioxBio specializes in the development and commercialization of proprietary synthetic small molecules.See details»
TrioxBio - Company Profile - Tracxn
TrioxBio - Developing nitric oxide-inhibiting drugs for migraine disorders. from 1 investor. TrioxBio has 283 competitors.See details»
TrioxBio, Inc. - Facebook
TrioxBio, Inc. 603 likes · 3 talking about this. Clinical-stage biotech company focusing on the development of nitric oxide synthase (NOS) inhibitorsSee details»
Trioxbio. Ltd.:Company Profile & Technical Research,Competitor …
TrioxBio is a company that provides Health care, Small molecule, Clinical trial and more. TrioxBio is headquartered in Israel Tel Aviv. TrioxBio was founded in 2015. Related Topics. Health care …See details»
TrioxBio - Tech Stack, Apps, Patents & Trademarks - Crunchbase
TrioxBio specializes in the development and commercialization of proprietary synthetic small molecules.See details»
trioxbio.com - TrioxBio - Triox Bio - Sur.ly
TrioxBio. TrioxBio's API, S-ethylisothiouronium diethylphosphate, MTR-104, is a Nitric Oxide Synthase (NOS) inhibitor which blocks the production of nitric oxide, preventing the dilation of …See details»
CEO – TrioxBio
“The FDA’s Office of Orphan Products Development granted TrioxBio Inc. its orphan-drug designation request of S-ethylisothiouroniumdiethylphosphate (MTR-107) for ...See details»
R&D – TrioxBio
MTR-106: Migraine TrioxBio plans to start a Phase II study for the migraine indication in Europe and the U.S. this year. The study will be a multicenter, randomized, double-blinded, placebo …See details»